KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Construction in Progress (2016 - 2022)

Historic Construction in Progress for Amgen (AMGN) over the last 14 years, with Q4 2022 value amounting to $1.2 billion.

  • Amgen's Construction in Progress rose 2289.77% to $1.2 billion in Q4 2022 from the same period last year, while for Dec 2022 it was $1.2 billion, marking a year-over-year increase of 2289.77%. This contributed to the annual value of $1.2 billion for FY2022, which is 2289.77% up from last year.
  • Per Amgen's latest filing, its Construction in Progress stood at $1.2 billion for Q4 2022, which was up 2289.77% from $987.0 million recorded in Q4 2021.
  • In the past 5 years, Amgen's Construction in Progress ranged from a high of $1.2 billion in Q4 2022 and a low of $907.0 million during Q4 2019
  • For the 5-year period, Amgen's Construction in Progress averaged around $995.0 million, with its median value being $953.0 million (2018).
  • As far as peak fluctuations go, Amgen's Construction in Progress crashed by 482.69% in 2019, and later skyrocketed by 2289.77% in 2022.
  • Amgen's Construction in Progress (Quarter) stood at $953.0 million in 2018, then fell by 4.83% to $907.0 million in 2019, then rose by 0.88% to $915.0 million in 2020, then grew by 7.87% to $987.0 million in 2021, then increased by 22.9% to $1.2 billion in 2022.
  • Its Construction in Progress stands at $1.2 billion for Q4 2022, versus $987.0 million for Q4 2021 and $915.0 million for Q4 2020.